Related Experiment Videos
Ventilator-associated pneumonia. A multivariate analysis
1Department of Internal Medicine, Washington University School of Medicine, St Louis, MO 63110.
JAMA
|October 27, 1993
Summary
Ventilator-associated pneumonia (VAP) affects 15.5% of ICU patients. Key risk factors include organ failure, older age, prior antibiotics, and supine positioning, highlighting areas for potential intervention.
Area of Science:
- Critical Care Medicine
- Infectious Diseases
- Respiratory Medicine
Background:
- Ventilator-associated pneumonia (VAP) is a significant complication in intensive care units (ICUs).
- Understanding the incidence and risk factors for VAP is crucial for improving patient outcomes.
Purpose of the Study:
- To identify factors associated with the development of VAP.
- To examine the incidence of VAP across different ICU populations.
Main Methods:
- An inception cohort study was conducted involving 277 patients requiring mechanical ventilation for over 24 hours.
- Patients were recruited from medical, surgical, and cardiothoracic ICUs.
- Prospective surveillance and data collection were employed to track VAP and mortality.
Main Results:
- VAP occurred in 15.5% of patients.
- Independent risk factors for VAP included a high organ system failure index, age 60+, prior antibiotic use, and supine head positioning.
- VAP incidence was higher in cardiothoracic ICUs (21.6%) compared to medical ICUs (9.3%).
- VAP was associated with significantly higher ICU mortality (37.2% vs. 8.5%).
Conclusions:
- The study identifies modifiable factors that may reduce VAP incidence and improve outcomes.
- Findings suggest that VAP incidence may vary across different ICU patient populations.